Artificial intelligence cuts cancer drug development time in half

By Anthony Cuthbertson | International Business Times –  A drug used to treat cancer was developed in half the time it normally takes and at a fraction of the cost after artificial intelligence (AI) was used in testing. US-based startup Berg Health expects to bring its BPM31410 drug − used to help fight cancers like pancreatic, bladder and brain − to market after just seven years, rather than the average of 14 years. AI was used in comparison tests between samples taken from cancer patients, processing vast amounts of data to work out disparities between the patients’ biological profiles. This is where the time saving was made. “We’re looking at 14 trillion data points in a single tissue sample,” Niven Narain, a clinical oncologist and co-founder of Berg Health, told The…


Link to Full Article: Artificial intelligence cuts cancer drug development time in half